Report Library
View More
Datamonitor Healthcare CV&Met: Veno...
September 3, 2026
Datamonitor Healthcare CV&Met: Atri...
September 3, 2026
Key Potential Drug Launches in 2027
September 1, 2026
HER2-Positive Breast Cancer KOL Int...
August 26, 2026
Datamonitor Healthcare CV&Met: Chem...
August 26, 2026
Datamonitor Healthcare Oncology: Sm...
August 26, 2026
Datamonitor Healthcare I&I: Glaucom...
August 26, 2026
HER2-Positive Breast Cancer KOL Int...
August 25, 2026
HER2-Positive Breast Cancer KOL Int...
August 24, 2026
HER2-Positive Breast Cancer KOL Int...
August 23, 2026
Datamonitor Healthcare Other: Erect...
August 19, 2026
Datamonitor Healthcare Other: Hypog...
August 19, 2026
Datamonitor Healthcare CV&Met: Amyl...
August 19, 2026
Datamonitor Healthcare Oncology: Tu...
August 19, 2026
Datamonitor Healthcare CNS: Neuropa...
August 19, 2026
Dealmaking Quarterly Statistics, Q2...
August 4, 2026
Financing Quarterly Statistics, Q2 ...
August 4, 2026
Datamonitor Healthcare CV&Met: Isch...
August 4, 2026
Datamonitor Healthcare Infectious D...
August 4, 2026
Datamonitor Healthcare Oncology: NH...
August 4, 2026
Impact Events
More| Date | Lead Company | Event | Type | Approval Change | Approval Likelihood |
|---|---|---|---|---|---|
| 8/29/26 | Tenax Therapeutics (TENX) | Simdax for Pulmonary Arterial Hypertension (PAH) and Pulmonary Hypertension (PH) | Subscribers Only | Subscribers Only | Subscribers Only |
| 8/28/26 | Cytokinetics (CYTK) | Myqorzo for Cardiomyopathy - Hypertrophic | Subscribers Only | Subscribers Only | Subscribers Only |
| 8/20/26 | Nuvation Bio (NUVB) | safusidenib erbumine for Brain Cancer (Malignant Glioma; AA and glioblastoma) | Subscribers Only | Subscribers Only | Subscribers Only |
| 8/19/26 | Xspray Pharma (XSPRAY) | Dasynoc for Acute Lymphoblastic Leukemia (ALL) | Subscribers Only | Subscribers Only | Subscribers Only |
| 8/19/26 | Xspray Pharma (XSPRAY) | Dasynoc for Chronic Myelogenous Leukemia (CML) | Subscribers Only | Subscribers Only | Subscribers Only |
Upcoming Catalysts
More| Expected Date Range | Lead Company | Drug | Expected Catalyst |
|---|---|---|---|
| 06/25/2025 | Subscribers Only | Subscribers Only | Company - Analyst/R&D Update |
| 06/25/2025 | Subscribers Only | Subscribers Only | Company - Analyst/R&D Update |
| 06/26/2025 | Subscribers Only | Subscribers Only | Company - Analyst/R&D Update |
| 09/08/2025 | Subscribers Only | Subscribers Only | Company - Analyst/R&D Update |
| 09/17/2025 | Subscribers Only | Subscribers Only | Company - Analyst/R&D Update |